Page 49 - MI-1-1
P. 49

Microbes & Immunity                                                  The feature of bladder cancer stem cells



            high-throughput single-cell sequencing of genomics,   Further disclosure
            epigenomics, transcriptomics, and proteomics from
            thousands of individual cells provides new insights into the   All figures are adopted from open-access articles.
            occurrence and recurrence of BC. It further confirms the   References
            mechanisms of relevant factors and cell-cell interactions,
            allowing  a  better  understanding  of  BC  with  different   1.   Sung H, Ferlay J, Siegel RL,  et al. Global cancer statistics
            molecular subtypes. This comprehensive understanding   2020: GLOBOCAN estimates of incidence and mortality
                                                                  worldwide for 36 cancers in 185 countries. CA Cancer J Clin.
            lays the theoretical foundation for precision medicine.   2021;71(3):209-249.
            Moreover, the efficacy of single treatment methods is
            often limited. Therefore, finding appropriate combination      doi: 10.3322/caac.21660
            therapies is essential to maximize the treatment outcomes   2.   Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A,
            for patients with BC.                                 Abnet CC. Association between smoking and risk of bladder
                                                                  cancer among men and women. JAMA. 2011;306(7):737-745.
            Acknowledgments
                                                                  doi: 10.1001/jama.2011.1142
            None.                                              3.   Rota M, Bosetti C, Boccia S, Boffetta P, La Vecchia  C.

            Funding                                               Occupational  exposures  to  polycyclic  aromatic
                                                                  hydrocarbons and respiratory and urinary tract cancers: An
            This work was supported by the Major Research Plan    updated systematic review and a meta-analysis to 2014. Arch
            of the National Natural Science Foundation of China   Toxicol. 2014;88(8):1479-1490.
            (92359202), Scientific and Technological Research      doi: 10.1007/s00204-014-1296-5
            Project of Xinjiang Production and Construction    4.   Akhtar S, Al-Shammari A, Al-Abkal J. Chronic urinary
            Corps (2022AB022), “Open Competition to Select the    tract infection and bladder carcinoma risk: A  meta-
            Best Candidates”Key Technology Program for Nucleic    analysis  of case-control  and  cohort studies.  World J Urol.
            Acid Drugs of NCTIB (NCTIB2022HS01016) and the        2018;36(6):839-848.
            Joint Project of Biomedical Translational Engineering      doi: 10.1007/s00345-018-2206-x
            Research Center of Beijing University of Chemical
            Technology-China-Japan   Friendship    Hospital    5.   Paonessa J, Beck H, Cook S. Squamous cell carcinoma of
            (XK2023-21).                                          the renal pelvis associated with kidney stones: A case report.
                                                                  Med Oncol. 2011;28 Suppl 1:S392-S394.
            Conflict of interest                                  doi: 10.1007/s12032-010-9704-z
            The authors declare no conflict of interest.       6.   Knight  A,  Askling  J,  Granath  F,  Sparen  P,  Ekbom  A.
                                                                  Urinary bladder cancer in Wegener’s granulomatosis:
            Author contributions                                  Risks and relation to cyclophosphamide. Ann Rheum Dis.

            Conceptualization: Liqi Yin, Zhao Yang                2004;63(10):1307-1311.
            Writing-original draft: Liqi Yin                      doi: 10.1136/ard.2003.019125
            Writing-review & editing: Zongyi Shen, Nan Zhang, Lu   7.   Miyazaki J, Nishiyama H. Epidemiology of urothelial
               Ying, Wenjing Zhang, Xiaoyang Chen, Youfeng Liang,   carcinoma. Int J Urol. 2017;24(10):730-734.
               Chunhui Li, Keying Yao, Changyuan Yu, Jiangfeng
               Wang, Zhao Yang                                    doi: 10.1111/iju.13376
                                                               8.   Knowles MA, Hurst CD. Molecular biology of bladder
            Ethics approval and consent to participate            cancer: New insights into pathogenesis and clinical diversity.
                                                                  Nat Rev Cancer. 2015;15(1):25-41.
            Not applicable.
                                                                  doi: 10.1038/nrc3817
            Consent for publication                            9.   Bladder Cancer: Diagnosis and management of bladder cancer:
            Not applicable.                                       © NICE (2015) Bladder cancer: Diagnosis and management of
                                                                  bladder cancer. BJU Int. 2017;120(6):755-765.
            Availability of data                                  doi: 10.1111/bju.14045
            The data that support the findings of the study are available   10.  Kirkali Z, Chan T, Manoharan M,  et al. Bladder cancer:
            from the corresponding author or other authors by email   Epidemiology, staging and grading, and diagnosis. Urology.
            upon reasonable request.                              2005;66(6 Suppl 1):4-34.


            Volume 1 Issue 1 (2024)                         43                               doi: 10.36922/mi.2377
   44   45   46   47   48   49   50   51   52   53   54